2021 annual financial data

Oncolytics Biotech Inc. 2021 Net margin

Oncolytics Biotech Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -20,925,470 CAD and net income was -20,980,772 CAD.
Operating cash flow was -22,434,009 CAD.

Get free Oncolytics Biotech Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 CAD
Operating income
-20,925,470 CAD
Net income
-20,980,772 CAD
Operating cash flow
-22,434,009 CAD